in genetics with genome-wide analysis study (GWAS) design
Category: RPRDx History
Early Adopter
of Affymetrix microarray technology for single nucleotide and copy number polymorphisms (SNP, CNP)
Early Adopter
of Affymetrix DMET™ microarray technology for pharmacogenomics-based personalized medicine
Established
advanced genomics diagnostic laboratory (CAP accredited) in joint venture between Medical College of WI and Children’s Hospital of WI specializing in cytogenetic/copy number analysis microarrays
Established
running DMET™ micoarrays clinically in second CLIA accredited diagnostic laboratory at Medical College of WI
Early Adopter
of Next Generation Sequencing (NGS)
Published
20+ PGx- and NGS-peer reviewed journal articles
Established
RPRD Diagnostics, LLC – first patient result reported on April 13th
First to Offer
Whole Pharmacogenomics Scan (WPS™) clinically
First to Offer
CEP72, NUDT15, and TPMT (CNT) Panel clinically